Staley Christopher, Vaughn Byron P, Graiziger Carolyn T, Singroy Stephanie, Hamilton Matthew J, Yao Dan, Chen Chi, Khoruts Alexander, Sadowsky Michael J
a BioTechnology Institute , University of Minnesota , St. Paul , Minnesota , USA.
b Division of Gastroenterology , Department of Medicine , University of Minnesota , Minneapolis , Minnesota , USA.
Gut Microbes. 2017 May 4;8(3):276-288. doi: 10.1080/19490976.2017.1299310. Epub 2017 Feb 28.
Fecal microbiota transplantation (FMT) is a highly effective treatment of recurrent and recalcitrant Clostridium difficile infection (rCDI). In a recent study oral-delivery of encapsulated, freeze-dried donor material, resulted in comparable rates of cure to colonoscopic approaches. Here we characterize shifts in the fecal bacterial community structure of patients treated for rCDI using encapsulated donor material. Prior to FMT, patient fecal samples showed declines in diversity and abundance of Firmicutes and Bacteroidetes, with concurrent increases in members of the Proteobacteria, specifically Enterobacteriaceae. Moreover, patients who experienced recurrence of CDI within the 2-month clinical follow-up had greater abundances of Enterobacteriaceae and did not show resolution of dysbioses. Despite resolution of rCDI following oral-administration of encapsulated fecal microbiota, community composition was slow to return to a normal donor-like assemblage. Post-FMT taxa within the Firmicutes showed rapid increases in relative abundance and did not vary significantly over time. Conversely, Bacteroidetes taxa only showed significant increases in abundance after one month post-FMT, corresponding to significant increases in the community attributable to the donors. Changes in the associations among dominant OTUs were observed at days, weeks, and months post-FMT, suggesting shifts in community dynamics may be related to the timing of increases in abundance of specific taxa. Administration of encapsulated, freeze-dried, fecal microbiota to rCDI patients resulted in restoration of bacterial diversity and resolution of dysbiosis. However, shifts in the fecal microbiome were incremental rather than immediate, and may be driven by changes in community dynamics reflecting changes in the host environment.
粪便微生物群移植(FMT)是治疗复发性和顽固性艰难梭菌感染(rCDI)的一种高效疗法。在最近一项研究中,口服封装的冻干供体材料,其治愈率与结肠镜检查方法相当。在此,我们描述了使用封装供体材料治疗rCDI的患者粪便细菌群落结构的变化。在FMT之前,患者粪便样本显示厚壁菌门和拟杆菌门的多样性和丰度下降,同时变形菌门成员(特别是肠杆菌科)增加。此外,在2个月临床随访期间经历CDI复发的患者,其肠杆菌科丰度更高,且未显示出菌群失调的缓解。尽管口服封装的粪便微生物群后rCDI得到缓解,但群落组成恢复到类似正常供体的组合较为缓慢。FMT后,厚壁菌门内的分类群相对丰度迅速增加,且随时间变化不显著。相反,拟杆菌门分类群仅在FMT后1个月丰度显著增加,这与来自供体的群落显著增加相对应。在FMT后的数天、数周和数月观察到优势OTU之间的关联变化,这表明群落动态变化可能与特定分类群丰度增加的时间有关。给rCDI患者施用封装的冻干粪便微生物群可恢复细菌多样性并缓解菌群失调。然而,粪便微生物组的变化是渐进的而非即时的,并且可能由反映宿主环境变化的群落动态变化所驱动。